Capital Opportunities for Small Businesses - sbtdc
Capital Opportunities for Small Businesses - sbtdc
Capital Opportunities for Small Businesses - sbtdc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PROFILES: VENTURE CAPITAL FUNDS ACTIVE IN NORTH CAROLINA<br />
(as of August 2011)<br />
Venture Firm<br />
Year<br />
Founded<br />
<strong>Capital</strong> Under<br />
Management<br />
Preferred Stage of<br />
Financing<br />
Preferred Size of<br />
Investment<br />
Preferred Industries<br />
Website Comments<br />
Delphi Ventures 1988 $1.1 billion Early Stage N/A<br />
Dow Venture <strong>Capital</strong> N/A >$350 million Start-up & Early Stage<br />
Easton Hunt <strong>Capital</strong><br />
Partners, LP (EHCP)<br />
Emerging Technology<br />
Partners, LLC (ETP)<br />
Envest Holdings, LLC-<br />
Envest Ventures I<br />
EuclidSR Partners-<br />
EuclidSR Partners II, LP<br />
Minimum: $250,000; Preferred:<br />
$500,000 to $5 million<br />
1993 >$110 million All Stages $1 million to $8 million<br />
N/A<br />
2000<br />
N/A<br />
($30 million<br />
projected)<br />
Early Stage (but will<br />
do Seed & Late Stage)<br />
Early Stage (~50%),<br />
Mid-Stage (~25%), &<br />
Later Stage/Buy-out<br />
(~25%)<br />
$500,000 to $3 million<br />
N/A $250 million All Stages $3 million to $10 million<br />
N/A<br />
Medical Devices & Diagnostics,<br />
Biotechnology, Healthcare Services.<br />
Life Sciences & Biotechnology,<br />
Communications & In<strong>for</strong>mation<br />
Technology, Electronics, and Materials<br />
Science. For a detailed list, visit:<br />
www.dow.com/venture/invest.<br />
Life Sciences; Industrial Manufacturing &<br />
Distribution; Software; and Energy.<br />
Exclusively in Life Sciences (antibody<br />
technologies, cell based technologies,<br />
drug delivery and discovery technologies,<br />
drug target discovery & validation,<br />
genome-based diagnostics, genomics<br />
tools, immunotherapy, proteomics).<br />
Broad ("expect a minimum of 50% to be<br />
invested in technology-based<br />
businesses").<br />
Healthcare (biotechnology, drug<br />
discovery & development technologies,<br />
medical device technologies);<br />
In<strong>for</strong>mation Technology; eHealth (the<br />
convergence of healthcare & IT).<br />
Frontier <strong>Capital</strong> LP 1999 $46 billion Expansion/growth $5-15 million Technology-enabled service businesses<br />
Gabriel Venture<br />
Partners<br />
N/A<br />
N/A<br />
Prefers to invest<br />
early, in emerging<br />
markets<br />
$500,000 to $7 million<br />
Communications & Networking, Internet,<br />
IT.<br />
99